Search research articles
Contact Us
Filters
Showing results (981-990 of 1,052) with videos related to
Page
of 106
Sort By:
The New England Journal of Medicine
|
December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E Brown, Darya Alizadeh, Renate Starr, et al.
Transplantation and Cellular Therapy
|
July 10, 2026
Impact of prior CAR T-cell treatment on graft-vs-host disease and non-relapse mortality after allogeneic transplantation
Tamer Othman, Dongyun Yang, Geoffrey Shouse, et al.
Cell Stem Cell
|
March 12, 2022
3D-organoid culture supports differentiation of human CAR<sup>+</sup> iPSCs into highly functional CAR T cells
Zhiqiang Wang, Helen P McWilliams-Koeppen, Hernan Reza, et al.
Medicine
|
September 1, 1996
Polymyositis as a manifestation of chronic graft-versus-host disease
P Parker, N J Chao, J Ben-Ezra, et al.
Blood
|
June 28, 2007
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
Christoph Kahl, Barry E Storer, Brenda M Sandmaier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2022
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
Ibrahim Aldoss, Samer K Khaled, Xiuli Wang, et al.
The Lancet. Haematology
|
November 20, 2022
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
Alex F Herrera, Lu Chen, Yago Nieto, et al.
Transplantation and Cellular Therapy
|
September 21, 2025
Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid Leukemia
Amandeep Salhotra, Nelli Bejanyan, Dongyun Yang, et al.
Blood Advances
|
May 13, 2020
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation
Monzr M Al Malki, Dongyun Yang, Myriam Labopin, et al.
Blood
|
November 1, 1995
Thalidomide as salvage therapy for chronic graft-versus-host disease
P M Parker, N Chao, A Nademanee, et al.
Page
of 106
Search research articles
Search
Showing results (981-990 of 1,052) with videos related to
Sort By:
Page
of 106
The New England Journal of Medicine
|
December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E Brown, Darya Alizadeh, Renate Starr, et al.
Transplantation and Cellular Therapy
|
July 10, 2026
Impact of prior CAR T-cell treatment on graft-vs-host disease and non-relapse mortality after allogeneic transplantation
Tamer Othman, Dongyun Yang, Geoffrey Shouse, et al.
Cell Stem Cell
|
March 12, 2022
3D-organoid culture supports differentiation of human CAR<sup>+</sup> iPSCs into highly functional CAR T cells
Zhiqiang Wang, Helen P McWilliams-Koeppen, Hernan Reza, et al.
Medicine
|
September 1, 1996
Polymyositis as a manifestation of chronic graft-versus-host disease
P Parker, N J Chao, J Ben-Ezra, et al.
Blood
|
June 28, 2007
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
Christoph Kahl, Barry E Storer, Brenda M Sandmaier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2022
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
Ibrahim Aldoss, Samer K Khaled, Xiuli Wang, et al.
The Lancet. Haematology
|
November 20, 2022
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
Alex F Herrera, Lu Chen, Yago Nieto, et al.
Transplantation and Cellular Therapy
|
September 21, 2025
Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid Leukemia
Amandeep Salhotra, Nelli Bejanyan, Dongyun Yang, et al.
Blood Advances
|
May 13, 2020
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation
Monzr M Al Malki, Dongyun Yang, Myriam Labopin, et al.
Blood
|
November 1, 1995
Thalidomide as salvage therapy for chronic graft-versus-host disease
P M Parker, N Chao, A Nademanee, et al.
Page
of 106